Immunogenicity and Safety Among Children and Adults of the 2009-2010 Trivalent Influenza Vaccine, 2008-2009 Trivalent Influenza Vaccine, and Quadrivalent Influenza Vaccine (Intramuscular Route).

Trial Profile

Immunogenicity and Safety Among Children and Adults of the 2009-2010 Trivalent Influenza Vaccine, 2008-2009 Trivalent Influenza Vaccine, and Quadrivalent Influenza Vaccine (Intramuscular Route).

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 22 Oct 2012 An overview of results from the quadrivalent influenza vaccine trials, including this trial, was presented at IDWeek, according to a Sanofi Pasteur media release.
    • 26 Oct 2010 Primary endpoint 'Geometric mean antibody titre' has been met.
    • 26 Oct 2010 Results were presented at the 48th Annual Meeting of the Infectious Diseases Society of America, according to a Sanofi Pasteur media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top